Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-06

Clinical Trial Update: Effect of Dupilumab on Aspirin Intolerance [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating the effect of dupilumab on aspirin intolerance in Aspirin Exacerbated Respiratory Disease (AERD).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dupilumab (dupilumab)

Snippet

Sponsor: Medical University of Vienna | Conditions: AERD - Aspirin Exacerbated Respiratory Disease | Phase 4 | Status: UNKNOWN